Uncommon tumors in multiple endocrine neoplasia (MEN) type 1: Do they have a relationship with the prognosis of these patients?

被引:5
作者
Febrero, B. [1 ]
Segura, P. [2 ]
Ruiz-Manzanera, J. J. [1 ]
Teruel, E. [3 ]
Ros, I. [1 ]
Rios, A. [1 ]
Hernandez, A. M. [2 ]
Rodriguez, J. M. [1 ]
机构
[1] Virgen Arrixaca Univ Hosp, Inst Murciano Invest Biosanitaria IMIB, Endocrine Surg Unit, Gen Surg Serv, Crta Madrid Cartagena S-N, Murcia 30120, Spain
[2] Virgen Arrixaca Univ Hosp, Serv Endocrinol, Murcia 30120, Spain
[3] Virgen Arrixaca Univ Hosp, Maxillofacial Surg Serv, Murcia 30120, Spain
关键词
Uncommon tumors; MEN; 1; Mortality; Pancreatic neuroendocrine tumors; Prognosis;
D O I
10.1007/s40618-020-01414-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The prognosis of MEN 1 patients is not only determined by pancreatic disease; it is also related to other uncommon tumors. The objective of this study is to analyze the tumors associated with MEN 1 outside the classic triad and to investigate their relationship with mortality. Materials and methods One hundred and five MEN 1 patients were studied in a tertiary referral hospital (1980-2019). Results With a follow-up of 11 +/- 4 years, seven patients died (8%), four as a consequence MEN syndrome. Thirty-three percent had adrenal gland tumors. One patient died of adrenal cancer. Eight percent presented with a neuroendocrine thoracic neoplasm, and one patient died. Another patient died due to cutaneous T-cell lymphoma. A further patient died because of a gastrinoma with liver metastasis. Conclusions To conclude, 75% of MEN-related deaths were the result of an uncommon pathology, and we, therefore, recommend that these tumors should be taken into account in the screening and follow-up of these patients.
引用
收藏
页码:1327 / 1330
页数:4
相关论文
共 10 条
[1]   Lethality of multiple endocrine neoplasia type I [J].
Doherty, GM ;
Olson, JA ;
Frisella, MM ;
Lairmore, TC ;
Wells, SA ;
Norton, JA .
WORLD JOURNAL OF SURGERY, 1998, 22 (06) :581-587
[2]   Aggressive adrenal carcinoma in a young patient with Multiple Endocrine Neoplasia 1 syndrome [J].
Febrero, Beatriz ;
Rios, Antonio ;
Rodriguez, Jose M. .
MEDICINA CLINICA, 2017, 149 (10) :463-463
[3]   Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'e ' tude des Tumeurs Endocrines database [J].
Gatta-Cherifi, B. ;
Chabre, O. ;
Murat, A. ;
Niccoli, P. ;
Cardot-Bauters, C. ;
Rohmer, V. ;
Young, J. ;
Delemer, B. ;
Du Boullay, H. ;
Verger, M. F. ;
Kuhn, J. M. ;
Sadoul, J. L. ;
Ruszniewski, Ph ;
Beckers, A. ;
Monsaingeon, M. ;
Baudin, E. ;
Goudet, P. ;
Tabarin, A. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (02) :269-279
[4]   Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients [J].
Goudet, Pierre ;
Murat, Arnaud ;
Binquet, Christine ;
Cardot-Bauters, Christine ;
Costa, Annie ;
Ruszniewski, Philippe ;
Niccoli, Patricia ;
Menegaux, Fabrice ;
Chabrier, Georges ;
Borson-Chazot, Francoise ;
Tabarin, Antoine ;
Bouchard, Philippe ;
Delemer, Brigitte ;
Beckers, Alfred ;
Bonithon-Kopp, Claire .
WORLD JOURNAL OF SURGERY, 2010, 34 (02) :249-255
[5]   Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines) [J].
Goudet, Pierre ;
Murat, Arnaud ;
Cardot-Bauters, Catherine ;
Emy, Philippe ;
Baudin, Eric ;
Choplin, Helene du Boullay ;
Chapuis, Yves ;
Kraimps, Jean-Louis ;
Sadoul, Jean-Louis ;
Tabarin, Antoine ;
Verges, Bruno ;
Carnaille, Bruno ;
Niccoli-Sire, Patricia ;
Costa, Annie ;
Calender, Alain .
WORLD JOURNAL OF SURGERY, 2009, 33 (06) :1197-1207
[6]   Clinical presentation and management of primary ovarian neuroendocrine tumor in multiple endocrine neoplasia type 1 [J].
Jhawar, Sakshi ;
Lakhotia, Rahul ;
Suzuki, Mari ;
Welch, James ;
Agarwal, Sunita K. ;
Sharretts, John ;
Merino, Maria ;
Ahlman, Mark ;
Blau, Jenny E. ;
Simonds, William F. ;
Del Rivero, Jaydira .
ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2019,
[7]   Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1) [J].
Thakker, Rajesh V. ;
Newey, Paul J. ;
Walls, Gerard V. ;
Bilezikian, John ;
Dralle, Henning ;
Ebeling, Peter R. ;
Melmed, Shlomo ;
Sakurai, Akihiro ;
Tonelli, Francesco ;
Brandi, Maria Luisa .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09) :2990-3011
[8]   MEN1-Dependent Breast Cancer: Indication for Early Screening? Results From the Dutch MEN1 Study Group [J].
van Leeuwaarde, Rachel S. ;
Dreijerink, Koen M. ;
Ausems, Margreet G. ;
Beijers, Hanneke J. ;
Dekkers, Olaf M. ;
de Herder, Wouter W. ;
van der Horst-Schrivers, Anouk N. ;
Drent, Madeleine L. ;
Bisschop, Peter H. ;
Havekes, Bas ;
Peeters, Petra H. M. ;
Pijnappel, Ruud M. ;
Vriens, Menno R. ;
Valk, Gerlof D. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (06) :2083-2090
[9]   Clinical features and prognosis of thymic neuroendocrine tumours associated with multiple endocrine neoplasia type 1: A single-centre study, systematic review and meta-analysis [J].
Ye, Lei ;
Wang, Weixi ;
Ospina, Naykky Singh ;
Jiang, Lei ;
Christakis, Ioannis ;
Lu, Jieli ;
Zhou, Yulin ;
Zhu, Wei ;
Cao, Yanan ;
Wang, Shu ;
Perrier, Nancy D. ;
Young, William F., Jr. ;
Ning, Guang ;
Wang, Weiqing .
CLINICAL ENDOCRINOLOGY, 2017, 87 (06) :706-716
[10]  
Yeh JE, 2017, DERMATOL ONLINE J, V23